Market Research Logo

Stentys SA (STNT) - Product Pipeline Analysis, 2016 Update

Summary

Stentys SA (Stentys) is a medical technology company that develops and offers solutions to cardiologists to treat patients with acute myocardial infarction and coronary disease. The company’s products include BMS and DES stents, and aspiration catheter stents. Stentys’s stent is designed with small distinctive interconnectors, which is implanted in the hand vessel over a single wire. The company markets products under brand names, namely, Self-Apposing and STENTYS. It has conducted clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Stentys, SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Stentys SA Company Snapshot
Stentys SA Company Overview
Stentys SA Pipeline Products and Clinical Trials Overview
Stentys SA – Pipeline Analysis Overview
Key Facts
Stentys SA - Major Products and Services
Stentys SA Pipeline Products by Development Stage
Stentys SA Pipeline Products Overview
Next-Generation Delivery System
Next-Generation Delivery System Product Overview
STENTYS Paclitaxel-Eluting Stent
STENTYS Paclitaxel-Eluting Stent Product Overview
STENTYS Self-Apposing Coronary Stent
STENTYS Self-Apposing Coronary Stent Product Overview
Stentys SA - Key Competitors
Stentys SA - Key Employees
Stentys SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Stentys SA, Recent Developments
Apr 13, 2016: STENTYS Reports 38% Increase in Revenues in First Quarter 2016
Mar 21, 2016: STENTYS Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Artery Disease
Mar 16, 2016: STENTYS Reports 2015 Annual Results
Feb 29, 2016: STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention
Feb 08, 2016: STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication
Jan 28, 2016: STENTYS: First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs Broadcasted Live at LINC International Congress
Jan 13, 2016: STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues
Oct 15, 2015: STENTYS Reports 84% Growth in Third-Quarter 2015 Revenues
Oct 12, 2015: STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years
Sep 28, 2015: STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Stentys SA Pipeline Products and Clinical Trials Overview
Stentys SA Pipeline Products by Equipment Type
Stentys SA Pipeline Products by Indication
Stentys SA, Key Facts
Stentys SA, Major Products and Services
Stentys SA Number of Pipeline Products by Development Stage
Stentys SA Pipeline Products Summary by Development Stage
Next-Generation Delivery System - Product Status
Next-Generation Delivery System - Product Description
STENTYS Paclitaxel-Eluting Stent - Product Status
STENTYS Paclitaxel-Eluting Stent - Product Description
STENTYS Self-Apposing Coronary Stent - Product Status
STENTYS Self-Apposing Coronary Stent - Product Description
Stentys SA, Key Employees
Stentys SA, Subsidiaries
List of Figures
Stentys SA Pipeline Products by Equipment Type
Stentys SA Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report